Back to the peptide atlas
Blends & catalogue termsNon-standardised blendNot FDA/EMA approved

Selank + Semax

Neuropeptide blend

Also known as: SK + XA · Selank/Semax blend

No account · this device only

The essentials at a glance

Classification
Non-standardised blend · Blends & catalogue terms
Mechanism
Non-standardised blend of two experimental neuropeptides
Evidence
Anecdotal
Status
Not FDA/EMA approved

Linked in communities to stress and cognition claims; clinical benefit and safety of the blend are unproven.

Distinction: This combination pairs two individually experimental neuropeptides; the blend is additionally not standardised.

Evidence strengthAnecdotal

Claims rely mostly on personal experience reports and vendor statements rather than controlled studies.

Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.

Research questions

Mechanism: Selank + Semax

01

Neuropeptide blend

This studies how two individually experimental peptides acting on the nervous system are marketed together by vendors, similar to combining two separate tools into a set without testing them together. Studies mostly look at the individual substances, not the combination.

02

Anxiolytic signalling

This studies how a peptide affects stress and anxiety responses in animal models, similar to observing whether an animal stays calmer in an unfamiliar environment. Behavioural tests and stress hormone levels are measured.

03

Neuroprotective signalling

This examines whether a substance can protect nerve cells from stress or damage, such as after oxygen deprivation in a cell model. Cell survival and signalling markers in nerve tissue under lab conditions are measured.

Simple example

Unstandardized mixture

Think of it like a recipe without fixed measurements, where each cook assembles the ingredients somewhat differently.

Without a fixed composition, effects and safety cannot be reliably compared from batch to batch.

Community themes

How communities discuss it

Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.

Stack and blend discussion

Users exchange self-assembled combinations of several peptides and compare perceived effects, often without the specific combination ever having been studied. Such stack recommendations are personal opinions, not vetted protocols.

Nootropic forums

Subjective effects on concentration, mood, or stress perception after taking experimental neuropeptides are discussed, often based on personal journals. Such self-reported impressions are strongly influenced by expectation and do not replace controlled studies.

Vendor marketing claims

Vendors often advertise products with broad efficacy claims, comparison tables against competitors, and customer quotes. Such marketing statements are driven by sales interest and do not constitute independent scientific proof of efficacy.

Evidence boundary

Clinical benefit and safety of the blend are unproven.

No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.